Evidence map›Paper›PMID 25927410›Full record

ArticleBMC infectious diseases2014

Multicenter case-control study protocol of pneumonia etiology in children: Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL network).

Valentina Sanchez Picot, Thomas Bénet, Melina Messaoudi, Jean-Noël Telles, Monidarin Chou, Tekchheng Eap, Jianwei Wang, Kunling Shen, Jean-William Pape, Vanessa Rouzier and 21 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Randomized Trial of Amoxicillin for Pneumonia in Pakistan.The New England journal of medicine · 2020
    Trial
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Should Controls With Respiratory Symptoms Be Excluded From Case-Control Studies of Pneumonia Etiology? Reflections From the PERCH Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Review
  15. Article
  16. Article
  17. Review
  18. Prevention and Control of Childhood Pneumonia and Diarrhea.Pediatric clinics of North America · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 18 institutions in 10 countries.

Valentina Sanchez PicotEmerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 21, Avenue Tony Garnier, Lyon, 69007, France. valentina.picot@fondation-merieux.org.
Thomas BénetInfection Control and Epidemiology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France. thomas.benet@chu-lyon.fr.
Melina MessaoudiEmerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 21, Avenue Tony Garnier, Lyon, 69007, France. melina.messaoudi@fondation-merieux.org.
Jean-Noël TellesEmerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 21, Avenue Tony Garnier, Lyon, 69007, France. jean-noel.telles@fondation-merieux.org.
Monidarin ChouFaculty of Pharmacy, University of Health Sciences, Phnom Penh, Cambodia. cmonidarin@uhs.edu.kh.
Tekchheng EapDepartment of Pneumology, National Pediatric Hospital, Phnom Penh, Cambodia. techheng@yahoo.com.
Jianwei WangMOH Key Laboratory of Systems Biology of Pathogens and Dr. Christophe Mérieux Laboratory, IPB, CAMS-Fondation Mérieux, Institute of Pathogen Biology (IPB), Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College), Beijing, China. wangjw28@163.com.
Kunling ShenKey Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics (Capital Medical University), Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China. kunlingshen1717@163.com.
Jean-William PapeGHESKIO (Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes) Centers, Port au Prince, Haiti. jwpape@gheskio.org.
Vanessa RouzierGHESKIO (Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes) Centers, Port au Prince, Haiti. vrouzier@gheskio.org.
Shally AwasthiChatrapati Shahuji Maharaj University, Lucknow, India. shally07@gmail.com.
Nitin PandeyChatrapati Shahuji Maharaj University, Lucknow, India. drnitinpandey@gmail.com.
Ashish BavdekarKEM Hospital Research Center, Pune, India. bavdekar@vsnl.com.
Sonali SanghviKEM Hospital Research Center, Pune, India. sanghsk@yahoo.com.
Annick RobinsonHôpital Femme-Mère-Enfant, Antananarivo, Madagascar. annicklalaina@yahoo.fr.
Bénédicte ContaminFondation Mérieux, Centre d'Infectiologie Charles Mérieux (CICM), Antananarivo, Madagascar. benedicte.contamin@fondation-merieux.org.
Jonathan HoffmannFondation Mérieux, Centre d'Infectiologie Charles Mérieux (CICM), Antananarivo, Madagascar. jonathan.hoffmann@fondation-merieux.org.
Maryam SyllaGabriel Touré Hospital, Bamako, Mali. dr_mame@yahoo.fr.
Souleymane DialloCentre d'Infectiologie Charles Mérieux (CICM), Bamako, Mali. souleymane.diallo@fondationmerieux-mali.org.
Pagbajabyn NymadawaMongolian Academy of Medical Sciences, Ulaanbaatar, Mongolia. nymadawa@gyals.mn.
Budragchaagiin Dash-YandagBayanzurkh District General Hospital, Ulaanbaatar, Mongolia. dashyandag@mobinet.mn.
Graciela RussomandoResearch Institute of Health, Asuncion, Paraguay. grusso@rieder.net.py.
Wilma BasualdoHospital Pediátrico "Niños de Acosta Ñu", San Lorenzo, Paraguay. wilmabasualdo@gmail.com.
Marilda M SiqueiraRespiratory virus Laboratory, Oswaldo Cruz Foundation, Hospital Bonsucesso, Rio de Janeiro, Brazil. mmsiq@ioc.fiocruz.br.
Patricia BarretoRespiratory virus Laboratory, Oswaldo Cruz Foundation, Hospital Bonsucesso, Rio de Janeiro, Brazil. pfbcosta@gmail.com.
Florence Komurian-PradelEmerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 21, Avenue Tony Garnier, Lyon, 69007, France. florence.pradel@fondation-merieux.org.
Guy VernetEmerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 21, Avenue Tony Garnier, Lyon, 69007, France. guy.vernet@hotmail.com.
Hubert EndtzEmerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 21, Avenue Tony Garnier, Lyon, 69007, France. hubert.endtz@fondation-merieux.org.
Philippe VanhemsInfection Control and Epidemiology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France. philippe.vanhems@chu-lyon.fr.
Gláucia Paranhos-BaccalàEmerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 21, Avenue Tony Garnier, Lyon, 69007, France. glaucia.baccala@fondation-merieux.org.
pneumonia GABRIEL network
Fondation Mérieux · FRInserm · FRChhatrapati Shahu Ji Maharaj University · INÉcole Normale Supérieure de Lyon · FRGheskio Centers · HTBeijing Children’s Hospital · CNCambodia National Malaria Center · KHCentre National de la Recherche Appliquée au Developpement Rural · MGCentre National de la Recherche Scientifique · FRChinese Academy of Medical Sciences & Peking Union Medical College · CNFundação Oswaldo Cruz · BRGuyra Paraguay · PYHospices Civils de Lyon · FRHospital Geral de Bonsucesso · BRMali-Folkecenter · MLMongolian Academy of Sciences · MNUniversité Claude Bernard Lyon 1 · FRUniversity of Health Science · KH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundData on the etiologies of pneumonia among children are inadequate, especially in developing countries. The principal objective is to undertake a multicenter incident case-control study of <5-year-old children hospitalized with pneumonia in developing and emerging countries, aiming to identify the causative agents involved in pneumonia while assessing individual and microbial factors associated with the risk of severe pneumonia. METHODS/

designA multicenter case-control study, based on the GABRIEL network, is ongoing. Ten study sites are located in 9 countries over 3 continents: Brazil, Cambodia, China, Haiti, India, Madagascar, Mali, Mongolia, and Paraguay. At least 1,000 incident cases and 1,000 controls will be enrolled and matched for age and date. Cases are hospitalized children <5 years with radiologically confirmed pneumonia, and the controls are children without any features suggestive of pneumonia. Respiratory specimens are collected from all enrolled subjects to identify 19 viruses and 5 bacteria. Whole blood from pneumonia cases is being tested for 3 major bacteria. S. pneumoniae-positive specimens are serotyped. Urine samples from cases only are tested for detection of antimicrobial activity. The association between procalcitonin, C-reactive protein and pathogens is being evaluated. A discovery platform will enable pathogen identification in undiagnosed samples. DISCUSSION: This multicenter study will provide descriptive results for better understanding of pathogens responsible for pneumonia among children in developing countries. The identification of determinants related to microorganisms associated with pneumonia and its severity should facilitate treatment and prevention.

Indexed as

Clinical ProtocolsDeveloping CountriesAnti-Bacterial AgentsBacteriaBrazilCalcitoninCalcitonin Gene-Related PeptideCambodiaCase-Control StudiesChild, PreschoolChinaC-Reactive ProteinFemaleHaitiHumansIndiaAnti-Bacterial AgentsCALCA protein, humanCalcitoninCalcitonin Gene-Related PeptideC-Reactive ProteinProtein Precursors

Identifiers

PMID25927410
PMCPMC4272811
OpenAlexW2171788911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.